AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Granot, E.
Right arrow Articles by Kohen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Granot, E.
Right arrow Articles by Kohen, R.
Agricola
Right arrow Articles by Granot, E.
Right arrow Articles by Kohen, R.
American Journal of Clinical Nutrition, Vol. 79, No. 2, 226-230, February 2004
© 2004 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATIONS

Oxidative stress in abetalipoproteinemia patients receiving long-term vitamin E and vitamin A supplementation1,2

Esther Granot and Ron Kohen

1 From the Department of Pediatrics, Hadassah University Hospital, Jerusalem (EG), and the Department of Pharmaceutics, School of Pharmacy, Hebrew University-Hadassah Medical School, Jerusalem (RK)

Background: Patients with abetalipoproteinemia develop progressive ataxic neuropathy and retinopathy that are thought to be due, in part, to oxidative damage resulting from deficiencies of vitamins E and A.

Objective: The goal was to determine the degree of oxidative stress in abetalipoproteinemia patients who had received vitamin E (100 mg/kg) and vitamin A (10 000-15 000 IU/d) since infancy.

Design: Ten patients aged 3-25 y were studied. Assessed were plasma carbonyl concentrations as a marker of oxidative damage to proteins; total plasma oxidizability, which was used to evaluate the susceptibility of plasma lipoproteins to oxidation; and cyclic voltammetry, which represents the overall reducing and antioxidant capacity stemming from low-molecular-weight antioxidants in plasma.

Results: Concentrations of plasma carbonyls did not differ significantly between patients and control subjects ( ± SE: 0.5670 ± 0.031 and 0.5039 ± 0.0134 nmol/mg protein, respectively). The lag phase of plasma oxidizability was 28.03 ± 3.16 min in the patients and 24.0 ± 2.79 min in healthy subjects in whom oxidizability of isolated HDL was measured (NS). Cyclic voltammetry showed a peak potential of 330 ± 8.3 mV in all samples studied, denoting that the same antioxidants were present in the plasma of the patients and the control subjects. The anodic current of the samples, a measure of the concentration of hydrophilic low-molecular-weight antioxidants, was 5.227 ± 0.25 and 5.38 ± 0.20 µA in the patients and the control subjects, respectively (NS).

Conclusion: Enhanced oxidative stress is not apparent in the plasma of abetalipoproteinemia patients receiving long-term supplementation with vitamins E and A.

Key Words: Abetalipoproteinemia • oxidative stress • vitamin E • vitamin A




This article has been cited by other articles:


Home page
Clin. Chem.Home page
M. W. Clarke, A. J. Hooper, H. A. Headlam, J. H.Y. Wu, K. D. Croft, and J. R. Burnett
Assessment of Tocopherol Metabolism and Oxidative Stress in Familial Hypobetalipoproteinemia
Clin. Chem., July 1, 2006; 52(7): 1339 - 1345.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The American Society for Nutrition